Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment

Patient Preferences for Anti-Vascular Endothelial Growth Factor Treatment for Wet Age-Related Macular Degeneration in Japan: A Discrete Choice Experiment

Takeshi Joko,1 Yoshimi Nagai,2 Ryusaburo Mori,3 Koji Tanaka,3 Yuji Oshima,4 Yusuke Hikichi,5 Tetsushi Komori,6 Joao Carrasco,7 Martine C Maculaitis,8 Oliver Will,8 Kathleen Beusterien,8 Kanji Takahashi2 1Department of Ophthalmology, Matsuyama Red Cross Hospital, Matsuyama, Ehime, Japan; 2Department...

Full description

Bibliographic Details
Main Authors: Joko T, Nagai Y, Mori R, Tanaka K, Oshima Y, Hikichi Y, Komori T, Carrasco J, Maculaitis MC, Will O, Beusterien K, Takahashi K
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Patient Preference and Adherence
Subjects:
wet age-related macular degeneration
patient preference
anti-vascular endothelial growth factor treatment
dosing regimen
treat-and-extend
every two-month dosing
pro re nata.
Online Access:https://www.dovepress.com/patient-preferences-for-anti-vascular-endothelial-growth-factor-treatm-peer-reviewed-article-PPA

Internet

https://www.dovepress.com/patient-preferences-for-anti-vascular-endothelial-growth-factor-treatm-peer-reviewed-article-PPA

Similar Items